Neurosurgeon Shares Five Evidence-Based Strategies for Brain Health
Dr. Randy D'Amico, a neurosurgeon at Northwell Lenox Hill Hospital, outlined five daily practices he uses to maintain brain health: exercise, diet, sleep, stress management, and social connection. The recommendations are grounded in existing research showing connections between physical wellness, cardiovascular health, nutrition, and cognitive function. Brain health maintenance is important because cognitive decline and conditions like Alzheimer's and dementia are linked to modifiable lifestyle factors.
Dr. Randy D'Amico, director of the Brain and Spine Metastasis Program at Northwell Lenox Hill Hospital, shared five strategies for maintaining brain health based on established research. Exercise, particularly resistance training combined with cardiovascular activity, promotes blood flow and oxygen delivery to the brain while strengthening gray matter. Diet plays an equally important role; D'Amico recommends Mediterranean-style eating patterns rich in protein, plants, healthy fats, and fiber while limiting processed foods and excess sugar, which can accelerate brain aging. Sleep is essential for memory consolidation and cognitive recovery. The article also references the gut-brain axis, suggesting that gut microbiome health influences brain function through inflammation and metabolism. D'Amico notes that while no single food provides magic protection, maintaining metabolic and vascular health supports overall brain function.
What's missing
The article appears to be truncated and does not include the complete discussion of all five strategies mentioned in the headline (stress management and social connection are referenced in the summary but not fully detailed in the provided text). Additionally, while the article cites 'existing research,' specific peer-reviewed studies or their citations are not provided.
What different sources said
- New York PostRight
I’m a neurosurgeon — 5 critical ways I keep my own brain healthy
Related
Multi-Cancer Blood Test Galleri Fails Primary Trial Endpoint
A major clinical trial of Galleri, a blood test designed to detect multiple cancers early, failed to meet its primary goal of reducing late-stage cancer diagnoses when results were announced in February. Multi-cancer early detection (MCED) tests aim to improve survival rates by identifying disease at earlier, more treatable stages. The failure raises questions about the effectiveness of this promising diagnostic approach despite initial scientific enthusiasm.
Study Uses CPAP Data to Measure Social Jet Lag in Sleep Apnea Patients
Researchers analyzed CPAP adherence records from nearly 3,000 obstructive sleep apnea patients to measure social jet lag—the circadian misalignment between work and free days. About 16-21% of patients showed moderate to severe social jet lag, with prevalence highest in younger and middle-aged adults and declining after age 65. The findings suggest CPAP devices could routinely screen for circadian misalignment, potentially identifying patients who need additional behavioral or activity-based interventions.
FDA Updates Alli Label to Warn of Rare but Potentially Fatal Kidney Problems
The FDA has approved updated labeling for Alli, an over-the-counter weight loss pill, to warn of rare risks including acute kidney injury, kidney stones, and oxalate nephropathy. The agency now instructs people with kidney disease history to consult a doctor before use and directs all users to stop taking the drug if they experience symptoms like back pain, blood in urine, or leg swelling. This warning is significant because Alli is the only OTC weight loss medication available in the U.S., and approximately 40 million people have used orlistat (Alli's generic form) since its approval in 1999.